---
title: Immunology CDMOs in Europe
path: /indications/immunology/europe
companies_count: 8
---

# Immunology CDMOs in Europe

8 published CDMOs match Immunology in Europe.

Locations in this set include United States, United Kingdom, France, China, India, and Australia.

Capabilities that show up most often in this set: CMC Analytical Development, Process Development, Cell Therapy Manufacturing, CMC Regulatory Submission Support, and Technology Transfer.

## Matching companies

- [Axplora](/companies/axplora)
  - Global CDMO and API manufacturer specializing in complex small molecule development, ADC manufacturing, HPAPIs, and hazardous chemistry across ten production sites in Europe, India, and the US.
- [Cell and Gene Therapy Catapult](/companies/ct)
  - UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.
- [Cell-Easy](/companies/cell-easy)
  - Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.
- [Charles River Laboratories](/companies/criver)
  - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
- [Dr. Reddy's Laboratories](/companies/drreddys)
  - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing.
- [HitGen Inc.](/companies/hitgen)
  - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
- [Oxford Biomedica](/companies/oxb)
  - Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.